Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Statistics
Want to see SG:T14 full AI Analyst Report?
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (T14) Stock Statistics & Valuation Metrics
Total Valuation
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S has a market cap or net worth of $3.80B. The enterprise value is $1.77B.
- Market Cap
- $3.80B
- Enterprise Value
- $1.77B
Share Statistics
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S has 200,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 200,000,000
- Owned by Insiders
- ―
- Owned by Institutions
- 0.01%
Financial Efficiency
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is 29.17%.
- Return on Equity (ROE)
- 0.30
- Return on Assets (ROA)
- 0.18
- Return on Invested Capital (ROIC)
- 29.17%
- Return on Capital Employed (ROCE)
- 0.35
- Revenue Per Employee
- 1.26M
- Profits Per Employee
- 547.82K
- Employee Count
- 3,890
- Asset Turnover
- 0.42
- Inventory Turnover
- 1.13
Valuation Ratios
The current PE Ratio of Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S is 33.25. Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S’s PEG ratio is -0.44.
- PE Ratio
- 33.25
- PS Ratio
- 4.72
- PB Ratio
- 4.79
- Price to FCF
- 32.82
- Price to Operating Cash Flow
- 36.94
- PEG Ratio
- -0.44
Income Statement
In the last 12 months, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S had revenue of 4.92B and earned 2.13B in profits. Earnings per share was 2.77.
- Revenue
- 4.92B
- Gross Profit
- 3.64B
- Operating Income
- 2.49B
- Pretax Income
- 2.49B
- Net Income
- 2.13B
- EBITDA
- 2.61B
- Earnings Per Share (EPS)
- 2.77
Cash Flow
In the last 12 months, operating cash flow was 808.84M and capital expenditures -134.79M, giving a free cash flow of 674.05M billion.
- Operating Cash Flow
- 808.84M
- Free Cash Flow
- 674.05M
- Free Cash Flow per Share
- 0.87
Dividends & Yields
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S pays an annual dividend of $0.18, resulting in a dividend yield of 13.96%
- Dividend Per Share
- $0.18
- Dividend Yield
- 13.96%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 3.05%
- Earnings Yield
- 3.01%
Stock Price Statistics
- Beta
- 0.26
- 52-Week Price Change
- -18.03%
- 50-Day Moving Average
- 2.56
- 200-Day Moving Average
- 2.76
- Relative Strength Index (RSI)
- 41.20
- Average Volume (3m)
- 132.21K
Important Dates
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 30, 2026
- Next Earnings Date
- Apr 01, 2027
- Ex-Dividend Date
- Jun 25, 2025
Financial Position
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S as a current ratio of 1.59, with Debt / Equity ratio of 0.88%
- Current Ratio
- 1.59
- Quick Ratio
- 1.34
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- -0.37
- Interest Coverage Ratio
- 271.71
Taxes
In the past 12 months, Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S has paid 376.70M in taxes.
- Income Tax
- 376.70M
- Effective Tax Rate
- 0.15
Enterprise Valuation
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S EV to EBITDA ratio is 19.30, with an EV/FCF ratio of 31.00.
- EV to Sales
- 4.46
- EV to EBITDA
- 19.30
- EV to Free Cash Flow
- 31.00
- EV to Operating Cash Flow
- 25.84
Balance Sheet
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S has $1.31B in cash and marketable securities with $94.90M in debt, giving a net cash position of $1.22B billion.
- Cash & Marketable Securities
- $1.31B
- Total Debt
- $94.90M
- Net Cash
- $1.22B
- Net Cash Per Share
- $6.10
- Tangible Book Value Per Share
- $7.65
Margins
Gross margin is 74.62%, with operating margin of 20.85%, and net profit margin of 19.20%.
- Gross Margin
- 74.62%
- Operating Margin
- 20.85%
- Pretax Margin
- 22.03%
- Net Profit Margin
- 19.20%
- EBITDA Margin
- 23.12%
- EBIT Margin
- 21.76%
Analyst Forecast
The average price target for Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -8.84%
- EPS Growth Forecast
- -73.56%
Scores
- Smart Score
- 5
- AI Score
- 67

